Postoperative radiation therapy in non-small cell lung cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 20, Issue 5, 1997, Pages 441-448

  Emami, B ^a,d   Kaiser, L ^b   Simpson, J ^a   Shapiro, S ^c   Roper, C ^b   Lockett, M A ^a  

^a Radiation Oncology Center   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Oncology Care Center   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Non small cell lung cancer; Radiation therapy

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LUNG HILUS; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; POSTOPERATIVE CARE; RADIATION DOSE; TREATMENT INDICATION;

ACTUARIAL ANALYSIS; ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE TABLES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PNEUMONECTOMY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0030810880     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199710000-00003     Document Type: Article

References (35)

1. Choi N, Grillo H, Gardiello M, et ai. Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma. hit J Radiât Oncol Biol Phys 1980;6:31-5.
2. Chung C, Stryker J, O'Neill M, et al. Evaluation of adjuvant postoperative radiotherapy for lung cancer. Int J Radiât Oncol Biol Phys 1982;8:1877-80.
3. Ferguson M, Little A, Colomb H, et al. The role of adjuvant therapy after resection of T1 N1 MO and T2 NI MO non-small cell lung cancer. J Thorac Cardiovasc Surg 1986;91:344-9.
4. Green N, Kurohara S, George F, et al. Postresection irradiation for primary lung cancer. Radiology 1975; 118:405-7.
5. Immerman S, Vanecko R, Fry W. Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure. Ann Thorac Surg 1981;32:23-7.
6. Kirsh M, Sloan H. Mediastinal metastases in bronchogenic carcinoma: influence of postoperative irradiation, cell type and location. Ann Thorac Surg 1982;33:459-63.
7. Mountain C. Assessment of the role of surgery for control of lung cancer. Ann Thorac Surg 1986;24:365-73.
8. Mountain C, McMurtrey M, Frazier O. Regional extension of lung cancer. Int J Radiat Oncol Biol Phys 1980;6:1013-20.
9. Mountain C. Biologic, physiologic, and technical determinants in surgical therapy for lung cancer. In: Straus M, ed. Lung cancer clinical diagnosis and treatment. New York: Grune & Stratton, 1983.
10. Shields T. Classification and prognosis of surgically treated patients with bronchial carcinoma: analysis of VASOG studies. Int J Radiat Oncol Biol Phys 1980;6:1021-7.
11. Van Houtte P, Rocmas P, Smets P, et al. Postoperative radiation therapy in lung cancer: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 1980;6:983-6.
12. American Joint Commission on Cancer. Manual for staging of cancer, 4th ed. Philadelphia: J. B. Lippincott, 1993.
13. Mountain C. A new international staging system for lung cancer. Chest 1986;89:225S-33S.
14. Holmes E. Surgical adjuvant therapy of non-small cell lung cancer. Chest 1986;89:295S-300S.
15. Lung Cancer Study Group. A randomized comparison of the effects of adjuvant therapy on resected stages II and III nonsmall cell carcinoma of the lung. Ann Surg 1985;202:335-41.
16. Van Houtte P. Postoperative radiotherapy for lung cancer. Lung Cancer 1991;7:57-64.
17. Emami B, Kim T, Roper C, et al. Postoperative radiation therapy in the management of lung cancer. Radiology 1987; 164:251-53.
18. Cutler S, Ederer F. Maximum utilization of the left table method in analyzing survival. J Chron Dis 1958;8:699-711.
19. Miller R. Sun-ival analysis. New York: John Wiley & Sons, 1981.
20. Tarone R, Ware J. On distribution free tests for equality of survival distributions. Biometrika 1977; 64:156-60.
21. Tarone R. Tests for trend in life table analysis. Biomelrika 1975;62:679-82.
22. Cox D. Regression models and life tables. J R Slat Soc 1972;34(series B):187-220.
23. Dixon W. BMDP statistical soft\rare. Los Angeles: University of California Press, 1988.
24. Cox J, Komaki R, Byhardt R. Is immediate chest radiotherapy obligatory for any or all patients with limited-stage non-small cell carcinoma of the lung? Yes. Cancer Treat Rep 1983; 67:327-31.
25. Herskovic A, Bauer M, Seydel H, et al. Postoperative thoracic irradiation with or without levamisol in non-small cell lung cancer: results of an RTOG study. Int J Radiat Oncol Biol Phys 1988; 14:37-42.
26. Cox J. The respective roles of radiation therapy and chemotherapy in non-small cell carcinoma of the lung with mediastinal but not distant metastasis (N2M0). Lung Cancer 1991; 7:65-9.
27. Holmes E, Bleehen N, Le Chevalier T, et al. Postoperative adjuvant treatments for non-small cell lung cancers: a consensus report. Lung Cancer 1991;7:11-3.
28. Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N EnSl J Med 1986;315:1377-8I.
29. Emami B. Management of hilar and mediastinal lymph nodes with radiation therapy in the treatment of lung cancer. In: Meyer J, ed. Frontiers in radiation therapy ami oncology, vol 28. Basel: Karger, 1994.
30. Martini N, Flehinger J, Nagasaki F, et al. Prognostic significance of Nl disease in carcinoma of the lung. J Thorac Cardiovasc Siirg 1983; 86:646-53.
31. Martini N, Burt M, Bains M, et al. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg 1992; 54:460-6.
32. American Thoracic Society. Clinical staging of primary lung cancer. American Thoracic Society, 1981:659-64.
33. Regnard J, Magdeleinat P, Azoulay D, et al. Results of resection for bronchogenic carcinoma with mediastinal lymph node mé tastases in selected patients. Enr J Cardiothorac Surg 1991; 5:583-7.
34. Larsson S. Pretreatment classification and staging of bronchogenic carcinoma. Scand J Thorac Cardiovasc Surg 1973; 10(suppI.):l-47.
35. Pearson F, DeLarue N, lives R, et al. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 1982;83:1-11.